CG
Cutler Group’s SPDR S&P Biotech ETF XBI Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-62,433
| Closed | -$5.57M | – | 1909 |
|
2023
Q4 | $5.57M | Buy |
62,433
+29,242
| +88% | +$2.61M | 0.5% | 29 |
|
2023
Q3 | $2.42M | Buy |
33,191
+26,310
| +382% | +$1.92M | 0.25% | 74 |
|
2023
Q2 | $572K | Sell |
6,881
-17,665
| -72% | -$1.47M | 0.08% | 175 |
|
2023
Q1 | $1.87M | Buy |
+24,546
| New | +$1.87M | 0.19% | 77 |
|
2022
Q4 | – | Sell |
-120,710
| Closed | -$9.57M | – | 2442 |
|
2022
Q3 | $9.57M | Buy |
120,710
+100,796
| +506% | +$7.99M | 0.65% | 10 |
|
2022
Q2 | $1.48M | Sell |
19,914
-98,945
| -83% | -$7.35M | 0.1% | 132 |
|
2022
Q1 | $10.7M | Buy |
118,859
+32,986
| +38% | +$2.96M | 0.56% | 14 |
|
2021
Q4 | $9.61M | Buy |
85,873
+40,609
| +90% | +$4.55M | 0.4% | 29 |
|
2021
Q3 | $5.69M | Buy |
+45,264
| New | +$5.69M | 0.26% | 50 |
|
2021
Q2 | – | Sell |
-3,000
| Closed | -$406K | – | 2797 |
|
2021
Q1 | $406K | Sell |
3,000
-9,852
| -77% | -$1.33M | 0.02% | 460 |
|
2020
Q4 | $1.81M | Buy |
+12,852
| New | +$1.81M | 0.09% | 143 |
|
2020
Q3 | – | Sell |
-15,752
| Closed | -$1.76M | – | 2346 |
|
2020
Q2 | $1.76M | Sell |
15,752
-104,583
| -87% | -$11.7M | 0.12% | 116 |
|
2020
Q1 | $9.32M | Buy |
120,335
+39,916
| +50% | +$3.09M | 0.48% | 11 |
|
2019
Q4 | $7.65M | Buy |
80,419
+32,980
| +70% | +$3.14M | 0.47% | 27 |
|
2019
Q3 | $3.62M | Buy |
47,439
+26,463
| +126% | +$2.02M | 0.33% | 32 |
|
2019
Q2 | $1.84M | Buy |
+20,976
| New | +$1.84M | 0.17% | 77 |
|
2019
Q1 | – | Sell |
-3,000
| Closed | -$215K | – | 2278 |
|
2018
Q4 | $215K | Buy |
+3,000
| New | +$215K | 0.02% | 380 |
|
2018
Q3 | – | Sell |
-103,456
| Closed | -$9.85M | – | 2262 |
|
2018
Q2 | $9.85M | Buy |
103,456
+100,556
| +3,467% | +$9.57M | 0.79% | 15 |
|
2018
Q1 | $254K | Sell |
2,900
-6,771
| -70% | -$593K | 0.02% | 472 |
|
2017
Q4 | $820K | Sell |
9,671
-11,664
| -55% | -$989K | 0.03% | 276 |
|
2017
Q3 | $1.85M | Buy |
21,335
+17,848
| +512% | +$1.54M | 0.07% | 160 |
|
2017
Q2 | $269K | Buy |
3,487
+800
| +30% | +$61.7K | 0.01% | 736 |
|
2017
Q1 | $186K | Sell |
2,687
-4,387
| -62% | -$304K | 0.01% | 871 |
|
2016
Q4 | $418K | Buy |
7,074
+3,658
| +107% | +$216K | 0.02% | 530 |
|
2016
Q3 | $226K | Sell |
3,416
-77,448
| -96% | -$5.12M | 0.01% | 711 |
|
2016
Q2 | $4.37M | Buy |
80,864
+76,045
| +1,578% | +$4.11M | 0.22% | 49 |
|
2016
Q1 | $248K | Sell |
4,819
-53,622
| -92% | -$2.76M | 0.02% | 527 |
|
2015
Q4 | $4.1M | Buy |
+58,441
| New | +$4.1M | 0.23% | 51 |
|